Position in ZTS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$70,481,078
-$96,029,173 QoQ
Shares Held
980,811
-30.4% QoQ
Ownership
0.237%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#72
of 1,412 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Capital Research Global Investors holds $379,822,888 across 2 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (18.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
19,297,680 | $309,341,810 | |
| 2 | ZTS |
Zoetis Inc.
This page
|
980,811 | $70,481,078 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70,481,078 | 980,811 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $166,510,251 | 1,408,597 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $179,815,527 | 1,429,149 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $208,161,562 | 1,422,646 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $221,127,587 | 1,417,939 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $232,931,672 | 1,414,708 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $178,687,612 | 1,096,714 | Shares | Defined | 2025-02-13 | |
| 2024-06-30 | $337,832,352 | 1,948,733 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $685,415,732 | 4,050,681 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $781,654,476 | 3,960,351 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $714,615,890 | 4,107,460 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $719,456,354 | 4,177,785 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $699,690,291 | 4,203,859 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $571,554,232 | 3,900,063 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $492,122,905 | 3,318,652 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $570,325,175 | 3,317,966 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $625,472,313 | 3,316,572 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $1,174,681,598 | 4,813,677 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $934,283,024 | 4,812,419 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $897,119,894 | 4,813,908 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $780,621,745 | 4,956,958 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $784,730,993 | 4,741,577 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $778,948,595 | 4,710,338 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $608,539,138 | 4,440,595 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $426,901,644 | 3,627,340 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||